摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(8S,9S,10R,11S,13S,14S,17R)-17-(2-(benzo[d]thiazol-2-ylthio)acetyl)-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-yclopenta[a]phenanthren-17-yl furan-2-carboxylate | 1166866-31-4

中文名称
——
中文别名
——
英文名称
(8S,9S,10R,11S,13S,14S,17R)-17-(2-(benzo[d]thiazol-2-ylthio)acetyl)-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-yclopenta[a]phenanthren-17-yl furan-2-carboxylate
英文别名
[(8S,9S,10R,11S,13S,14S,17R)-17-[2-(1,3-benzothiazol-2-ylsulfanyl)acetyl]-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl] furan-2-carboxylate
(8S,9S,10R,11S,13S,14S,17R)-17-(2-(benzo[d]thiazol-2-ylthio)acetyl)-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-yclopenta[a]phenanthren-17-yl furan-2-carboxylate化学式
CAS
1166866-31-4
化学式
C33H33NO6S2
mdl
——
分子量
603.76
InChiKey
FMDLAZKDTJFMNF-XRPUJFATSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.6
  • 重原子数:
    42
  • 可旋转键数:
    7
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    160
  • 氢给体数:
    1
  • 氢受体数:
    9

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Channel Expansion in the Ligand-Binding Domain of the Glucocorticoid Receptor Contributes to the Activity of Highly Potent Glucocorticoid Analogues
    作者:Wesley B. Seaton、Susan J. Burke、Alexander R. Fisch、William A. Schilletter、Mary Grace A. Beck、Gabrielle A. Cassagne、Innocence Harvey、Molly S. Fontenot、J. Jason Collier、Shawn R. Campagna
    DOI:10.3390/molecules29071546
    日期:——

    Glucocorticoids (GCs) act through the glucocorticoid receptor (GR) and are commonly used as anti-inflammatory and immunosuppressant medications. Chronic GC use has been linked with unwanted complications such as steroid-induced diabetes mellitus (SIDM), although the mechanisms for these effects are not completely understood. Modification of six GC parent molecules with 2-mercaptobenzothiazole resulted in consistently less promoter activity in transcriptional activation assays using a 3xGRE reporter construct while constantly reducing inflammatory pathway activity. The most selective candidate, DX1, demonstrated a significant reduction (87%) in transactivation compared to commercially available dexamethasone. DX1 also maintained 90% of the anti-inflammatory potential of dexamethasone while simultaneously displaying a reduced toxicity profile. Additionally, two novel and highly potent compounds, DX4 and PN4, were developed and shown to elicit similar mRNA expression at attomolar concentrations that dexamethasone exhibits at nanomolar dosages. To further explain these results, Molecular Dynamic (MD) simulations were performed to examine structural changes in the ligand-binding domain of the glucocorticoid receptor in response to docking with the top ligands. Differing interactions with the transcriptional activation function 2 (AF-2) region of the GR may be responsible for lower transactivation capacity in DX1. DX4 and PN4 lose contact with Arg611 due to a key interaction changing from a stronger hydrophilic to a weaker hydrophobic one, which leads to the formation of an unoccupied channel at the location of the deacylcortivazol (DAC)-expanded binding pocket. These findings provide insights into the structure–function relationships important for regulating anti-inflammatory activity, which has implications for clinical utility.

  • Steroidal C-21 mercapto derivatives as dissociated steroids: Discovery of an inhaled dissociated steroid
    作者:Purakkattle Biju、Kevin McCormick、Robert Aslanian、Michael Berlin、Daniel Solomon、Richard Chapman、Robbie McLeod、Daniel Prelusky、Stephen Eckel、George Kelly、Michelle Natiello、Aileen House、Xiomara Fernandez、Rema Bitar、Jonathan Phillips、John Anthes
    DOI:10.1016/j.bmcl.2011.08.108
    日期:2011.11
    A series of C-21 mercapto derivatives of hydrocortisone have been synthesized and evaluated in cell based transrepression and transactivation assays. The benzothiazole derivative, compound 6 not only showed a dissociated profile in vitro functional assays but also a pharmacological profile in a Brown-Norway rat therapeutic index model of asthma that dissociated side effects (thymolysis) while maintaining efficacy against pulmonary inflammation and lung function. (C) 2011 Elsevier Ltd. All rights reserved.
查看更多